TRIPELENNAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Tripelennamine Hydrochloride patents expire, and when can generic versions of Tripelennamine Hydrochloride launch?
Tripelennamine Hydrochloride is a drug marketed by Anabolic, Barr, Heather, Impax Labs, Lannett, Nylos, Parke Davis, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in TRIPELENNAMINE HYDROCHLORIDE is tripelennamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tripelennamine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIPELENNAMINE HYDROCHLORIDE?
- What are the global sales for TRIPELENNAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for TRIPELENNAMINE HYDROCHLORIDE?
Summary for TRIPELENNAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 712 |
| DailyMed Link: | TRIPELENNAMINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRIPELENNAMINE HYDROCHLORIDE
US Patents and Regulatory Information for TRIPELENNAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anabolic | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083037-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083625-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 080785-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083626-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Barr | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 080744-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heather | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083989-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
